(Q48532439)

English

T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas

scientific article published in January 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

author name string

Ramon Sanchez

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Christopher Williams

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Jose L Daza

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Qinghong Dan

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Qingcheng Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Yijun Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Christina Delgado

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Neary Arpajirakul

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Edward W B Jeffes

9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Ronald C Kim

10

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Thomas Douglass

11

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Usama Al Atar

12

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

H Terry Wepsic

13

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Martin R Jadus

14

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Cellular Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

215

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

1-11

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

A comparison of treatment results for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Immunohistological study of mononuclear cell infiltrate in malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Induction of interferon-gamma inducing factor in the adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Interferon-alpha and -gamma expression in the rat testis

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracrani

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Cytotoxic properties of CD4(+) T-cell clones which lyse HLA class II negative autologous non-small-cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

The prospects for cancer gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900011-4

7 January 2021

Identifiers

10.1016/S0008-8749(02)00011-4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/12142031

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48532439&oldid=2240141913"